Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Ambrosini

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Neuroscience Letters|May 12, 2009
The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibilityMara D'Onofrio, Anna Ambrosini, Alessandra Di Mambro, et al.
Cephalalgia : an International Journal of Headache|February 22, 2024
Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with auraMichele Viana, Anders Hougaard, Erling Tronvik, et al.
Orphanet Journal of Rare Diseases|June 9, 2019
"Be an ambassador for change that you would like to see": a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular diseaseAnna Ambrosini, Ros Quinlivan, Valeria A Sansone, et al.
The Journal of Headache and Pain|January 12, 2018
Cerebral gray matter volume in patients with chronic migraine: correlations with clinical featuresGianluca Coppola, Barbara Petolicchio, Antonio Di Renzo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 16, 2025
The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectivenessFabrizio Vernieri, Anna Ambrosini, Marco Bartolini, et al.
Prion|June 23, 2022
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagementGianluigi Forloni, Ignazio Roiter, Vladimiro Artuso, et al.
Neurology and Therapy|February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Journal of Neuromuscular Diseases|February 5, 2019
The Position of Neuromuscular Patients in Shared Decision Making. Report from the 235th ENMC Workshop: Milan, Italy, January 19-20, 2018Hanns Lochmüller, Anna Ambrosini, Baziel van Engelen, et al.
International Journal of Environmental Research and Public Health|August 8, 2018
Recommendations for Improving the Quality of Rare Disease RegistriesYllka Kodra, Jérôme Weinbach, Manuel Posada-de-la-Paz, et al.
Journal of Neurology|October 29, 2013
Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and EuropeCatherine L Bladen, Rachel Thompson, Jacqueline M Jackson, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Neuroscience Letters|May 12, 2009
The interplay of two single nucleotide polymorphisms in the CACNA1A gene may contribute to migraine susceptibilityMara D'Onofrio, Anna Ambrosini, Alessandra Di Mambro, et al.
Cephalalgia : an International Journal of Headache|February 22, 2024
Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with auraMichele Viana, Anders Hougaard, Erling Tronvik, et al.
Orphanet Journal of Rare Diseases|June 9, 2019
"Be an ambassador for change that you would like to see": a call to action to all stakeholders for co-creation in healthcare and medical research to improve quality of life of people with a neuromuscular diseaseAnna Ambrosini, Ros Quinlivan, Valeria A Sansone, et al.
The Journal of Headache and Pain|January 12, 2018
Cerebral gray matter volume in patients with chronic migraine: correlations with clinical featuresGianluca Coppola, Barbara Petolicchio, Antonio Di Renzo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 16, 2025
The second interim analysis of Italian participants enrolled in the real-world, Pan-European, prospective, observational, Phase 4 PEARL study of fremanezumab effectivenessFabrizio Vernieri, Anna Ambrosini, Marco Bartolini, et al.
Prion|June 23, 2022
Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagementGianluigi Forloni, Ignazio Roiter, Vladimiro Artuso, et al.
Neurology and Therapy|February 8, 2024
Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)Fabrizio Vernieri, Luigi Francesco Iannone, Simona Guerzoni, et al.
Journal of Neuromuscular Diseases|February 5, 2019
The Position of Neuromuscular Patients in Shared Decision Making. Report from the 235th ENMC Workshop: Milan, Italy, January 19-20, 2018Hanns Lochmüller, Anna Ambrosini, Baziel van Engelen, et al.
International Journal of Environmental Research and Public Health|August 8, 2018
Recommendations for Improving the Quality of Rare Disease RegistriesYllka Kodra, Jérôme Weinbach, Manuel Posada-de-la-Paz, et al.
Journal of Neurology|October 29, 2013
Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and EuropeCatherine L Bladen, Rachel Thompson, Jacqueline M Jackson, et al.
Pageof 6